CDE-001

N/A

Report date: 2025/01/26 17:46:11
NME

Base Information

Drug NameCDE-001
Drug Alias NameNFkappaB/PPAR agonists (VivaCell Biotechnology)CDE-001
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsPeroxisome proliferator activated receptor agonists
TargetsPeroxisome proliferator activated receptorNuclear factor NF-kappa-B complex
Therapy Area/IndicationsMetabolic SyndromeDermatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEmerald Health Biotechnology España SLU
China Registration ClassN/A

Develop Information

Active CompaniesEmerald Health Biotechnology España SLU
Inactive CompaniesN/A
Active IndicationsDermatitis
Inactive IndicationsMetabolic Syndrome

Other Information

ATC CodeN/A
Related LinksN/A